Department of Medical Biochemistry, University of Belgrade-Faculty of Pharmacy, 11000 Belgrade, Serbia.
Clinical Hospital Center "Dr Dragiša Mišovic-Dedinje", 11000 Belgrade, Serbia.
Medicina (Kaunas). 2022 Dec 17;58(12):1866. doi: 10.3390/medicina58121866.
Background and Objectives: Diabetic foot (DF) development is driven by complex interactions of hyperglycemia, inflammation, and oxidative stress (OS). We aimed to investigate OS and inflammatory biomarkers in patients with DF and their potential to improve early diagnosis and management of DF. Materials and Methods: The prooxidant−antioxidant balance (PAB), superoxide dismutase (SOD), total oxidative status (TOS), total sulfhydryl groups (SHG), routine biochemical parameters, and complete blood count were determined in 42 patients with type-2 DM, of which 23 patients had DF, while 19 patients were without DF complications. The neutrophils-to-lymphocyte ratio (NLR) was evaluated as a biomarker of inflammation. Results: Patients with DF had significantly higher (p < 0.05) PAB levels (170 ± 33.9 U/L) compared to those without DF complications (142 ± 31.3 U/L). In addition, patients with DF had significantly reduced SOD activities (p < 0.01). NLR values were significantly higher in the DF group (median: 2.8; interquartile range: 2.0−4.3) than in the group without DF (median: 1.4; interquartile range: 1.4−2.1; p < 0.01). A positive correlation was found between the PAB and NLR index (r = 0.449; p < 0.05). The diagnostic accuracy of both PAB (AUC = 0.741; p < 0.01) and NLR (AUC = 0.760; p < 0.01) was estimated as acceptable. Conclusions: In conclusion, the development of DF is associated with enhanced OS and inflammation processes. PAB and NLR could be useful non-invasive biomarkers of DF development.
糖尿病足(DF)的发展是由高血糖、炎症和氧化应激(OS)的复杂相互作用驱动的。我们旨在研究 DF 患者的 OS 和炎症生物标志物及其在改善 DF 早期诊断和管理方面的潜力。
在 42 名 2 型糖尿病患者中测定了促氧化剂-抗氧化剂平衡(PAB)、超氧化物歧化酶(SOD)、总氧化状态(TOS)、总巯基基团(SHG)、常规生化参数和全血细胞计数,其中 23 名患者患有 DF,19 名患者无 DF 并发症。中性粒细胞与淋巴细胞比值(NLR)作为炎症的生物标志物进行评估。
DF 患者的 PAB 水平(170 ± 33.9 U/L)明显高于无 DF 并发症患者(142 ± 31.3 U/L)(p < 0.05)。此外,DF 患者的 SOD 活性明显降低(p < 0.01)。DF 组的 NLR 值明显高于无 DF 组(中位数:2.8;四分位距:2.0-4.3)(中位数:1.4;四分位距:1.4-2.1;p < 0.01)。PAB 和 NLR 指数之间存在正相关(r = 0.449;p < 0.05)。PAB(AUC = 0.741;p < 0.01)和 NLR(AUC = 0.760;p < 0.01)的诊断准确性均估计为可接受。
总之,DF 的发展与增强的 OS 和炎症过程有关。PAB 和 NLR 可能是 DF 发展的有用非侵入性生物标志物。